Skip to main content
The BMJ logoLink to The BMJ
letter
. 1995 Nov 4;311(7014):1232. doi: 10.1136/bmj.311.7014.1232

Polymyalgia rheumatica and giant cell arteritis.

A B Myles
PMCID: PMC2551156  PMID: 7488934

Full text

PDF

Page 1232

1232

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ferris J., Lamb R. Polymyalgia rheumatica and giant cell arteritis. High dose corticosteroids are recommended. BMJ. 1995 Aug 12;311(7002):455–455. doi: 10.1136/bmj.311.7002.455a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Myles A. B., Perera T., Ridley M. G. Prevention of blindness in giant cell arteritis by corticosteroid treatment. Br J Rheumatol. 1992 Feb;31(2):103–105. doi: 10.1093/rheumatology/31.2.103. [DOI] [PubMed] [Google Scholar]
  3. Pountain G., Hazleman B. ABC of rheumatology. Polymyalgia rheumatica and giant cell arteritis. BMJ. 1995 Apr 22;310(6986):1057–1059. doi: 10.1136/bmj.310.6986.1057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Rubinow A., Brandt K. D., Cohen A. S., Sack B. Iatrogenic morbidity accompanying suppression of temporal arteritis by adrenal corticosteroids. Ann Ophthalmol. 1984 Mar;16(3):258-60, 262, 264-5. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES